BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
FOXP1
,
Apoptosis
,
Lung cancer
,
Hippocampus
,
Human chorionic gonadotropin
,
rs6983267
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Nact
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Liver
Parotid gland
Fetal liver
Salivary gland
Amygdala
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Acute hepatic failure
Hepatic failure
Injury of liver
Urogenital injury
Liver regeneration
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
trovafloxacin
Roflumilast
1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole
Gentian Violet
lornoxicam
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
Trp53cor1
hsa-miR-31-5p
DUOX1
PHEX
PPP1R3C
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
The neuroimaging spectrum of SLC13A5 related developmental and epileptic encephalopathy.
Carbamazepine efficacy in a severe electro-clinical presentation of SLC13A5-epilepsy.
The citrate transporters SLC13A5 and SLC25A1 elicit different metabolic responses and phenotypes in …
SLC13A5 Deficiency Disorder: From Genetics to Gene Therapy.
Structure and inhibition mechanism of the human citrate transporter NaCT.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Target Volume Delineation After NACT in LA-NPCarcinoma Patients Treated With NACT+ CCRT
BRCA and NACT in TNBC Patients
HIPEC After Initial CRS in Patients Who Have Received NACT
Study of GEN-1 With NACT for Treatment of Ovarian Cancer (OVATION 2)
Selective Omission of Axillary Surgery in Triple-negative and HER2-positive Breast Cancer After NACT
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ